Intuits Latest Earnings Could Challenge Morgan Stanleys Stock Forecast US Consumer Sentiment Remains Strained Amid Inflation Geopolitical Conflicts and Trade Policy Uncertainty Toll Brothers Opens New Amenities at Cross Kirkland Towns in Washington Suburb Kevin Warsh Set to Assume Federal Reserve Chairmanship on Friday Microns AI Memory Demand Surge CEO Highlights 5066 Supply Gap as HBM Pricing Soars Beyond to Purchase Buy Buy Baby Brand Rights Reuniting with Bed Bath Beyond MRAM Q1 2026 Earnings EPS Surprises to the Upside as Stock Gains ORC Q1 2026 Earnings Strong EPS Beat Amid Stock Decline HA Sustainable Infrastructure Capital Inc HASI Q1 2026 Earnings Strong EPS Beat Mitigates Revenue Uncertainty Stock Holds Steady CLSK Q1 2026 Earnings Significant EPS Miss Amid Bitcoin Mining Headwinds OBK Q1 2026 Earnings Earnings Miss but Stock Rises Amid Resilient Core Operations MetLife MET Q1 2026 Earnings EPS Surpasses Estimates by 549 Aduro Clean Technologies ADUR Shows Resilience Up 217 as Shares Approach Key Resistance America Movil AMX Holds Near Support Amid Modest Decline Key Levels in Focus Sotherly Hotels Preferred Stock SOHON Holds Steady Near Support Levels Lifevantage LFVN Surges 45 on Rising Volume Testing Key Resistance at 589 Talkspace TALK Holds Steady Near Key Support Level Pope Leo Warns AI Needs to Be Disarmed Citing ProfitDriven Risks Leggett Platt Q1 2026 Earnings EPS Miss Weighs on Investor Sentiment Empery Digital Inc EMPD Retreats After Failed Upside Test Support at 472 in Focus KEP Q4 2025 Earnings EPS Misses Estimates Amid Operational Challenges LANDO Q1 2026 Earnings Preferred Stock Stays Steady With Slight EPS Beat CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue ACAD Q1 2026 Earnings EPS Misses Estimates as Biotech Faces Profitability Headwinds INFU Q1 2026 Earnings Strong EPS Beat Offsets Cautious Market Sentiment BBGI Q4 2025 Earnings Significant Loss Reported Shares Rally on Positives Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline